SK281193B6 - Tableta so zlepšenou biodostupnosťou účinnej látky, kyseliny klodrónovej, spôsob jej výroby a použitie mikrokryštalickej celulózy - Google Patents

Tableta so zlepšenou biodostupnosťou účinnej látky, kyseliny klodrónovej, spôsob jej výroby a použitie mikrokryštalickej celulózy Download PDF

Info

Publication number
SK281193B6
SK281193B6 SK48-95A SK4895A SK281193B6 SK 281193 B6 SK281193 B6 SK 281193B6 SK 4895 A SK4895 A SK 4895A SK 281193 B6 SK281193 B6 SK 281193B6
Authority
SK
Slovakia
Prior art keywords
tablet
weight
clodronic acid
active ingredient
microcrystalline cellulose
Prior art date
Application number
SK48-95A
Other languages
English (en)
Slovak (sk)
Other versions
SK4895A3 (en
Inventor
Walter Preis
Bernd M�Sel
G�Nter Neugebauer
Rolf-Dieter Gabel
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25927331&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK281193(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE9307393U external-priority patent/DE9307393U1/de
Priority claimed from DE19934322057 external-priority patent/DE4322057A1/de
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of SK4895A3 publication Critical patent/SK4895A3/sk
Publication of SK281193B6 publication Critical patent/SK281193B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK48-95A 1993-05-15 1993-07-24 Tableta so zlepšenou biodostupnosťou účinnej látky, kyseliny klodrónovej, spôsob jej výroby a použitie mikrokryštalickej celulózy SK281193B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE9307393U DE9307393U1 (de) 1993-05-15 1993-05-15 Tablette mit verbesserter Bioverfügbarkeit, enthaltend Dichlormethylendiphosphonsäure als Wirkstoff
DE19934322057 DE4322057A1 (de) 1993-07-02 1993-07-02 Tablette mit verbesserter Bioverfügbarkeit enthaltend Dichlormethylendiphosphonsäure als Wirkstoff
PCT/EP1993/001967 WO1994026310A1 (de) 1993-05-15 1993-07-24 Tablette mit verbesserter bioverfügbarkeit enthaltend dichlormethylendiphosphonsäure als wirkstoff

Publications (2)

Publication Number Publication Date
SK4895A3 SK4895A3 (en) 1997-01-08
SK281193B6 true SK281193B6 (sk) 2001-01-18

Family

ID=25927331

Family Applications (1)

Application Number Title Priority Date Filing Date
SK48-95A SK281193B6 (sk) 1993-05-15 1993-07-24 Tableta so zlepšenou biodostupnosťou účinnej látky, kyseliny klodrónovej, spôsob jej výroby a použitie mikrokryštalickej celulózy

Country Status (25)

Country Link
US (1) US5650168A (el)
EP (2) EP0625355B2 (el)
JP (1) JP3699110B2 (el)
KR (1) KR100263284B1 (el)
CN (1) CN1041797C (el)
AT (2) ATE128363T1 (el)
AU (1) AU687744B2 (el)
BR (1) BR9307859A (el)
CA (1) CA2162470C (el)
CZ (1) CZ287984B6 (el)
DE (1) DE59300688D1 (el)
DK (1) DK0625355T5 (el)
ES (1) ES2065313T5 (el)
FI (1) FI111519B (el)
GR (2) GR940300095T1 (el)
HU (1) HU220872B1 (el)
IL (1) IL106743A (el)
NO (1) NO307548B1 (el)
NZ (1) NZ254765A (el)
PL (1) PL173026B1 (el)
RU (1) RU2134103C1 (el)
SK (1) SK281193B6 (el)
TW (1) TW350772B (el)
UA (1) UA39884C2 (el)
WO (1) WO1994026310A1 (el)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI94926C (fi) * 1993-11-12 1995-11-27 Leiras Oy Menetelmä klodronaattivalmisteen valmistamiseksi
DE19615812A1 (de) * 1996-04-20 1997-10-23 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation
DE19719680A1 (de) 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
FI109088B (fi) * 1997-09-19 2002-05-31 Leiras Oy Tabletti ja menetelmä sen valmistamiseksi
EP0998932A1 (de) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
SE9901272D0 (sv) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
CZ289261B6 (cs) * 2000-07-11 2001-12-12 Léčiva, A.S. Tableta vyrobitelná přímým tabletováním, obsahující aktivní látku kyselinu 4-amino-1-hydroxybutyliden-1,1-bisfosfonovou, a způsob její výroby
CA2543353C (en) * 2003-09-19 2012-05-15 Sun Pharmaceutical Industries Limited Oral drug delivery system
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US7151400B2 (en) * 2004-07-13 2006-12-19 Taiwan Semiconductor Manufacturing Company, Ltd. Boost-biased level shifter
CN100370972C (zh) * 2006-01-10 2008-02-27 北京申科联华科技有限公司 一种具有益气养阴、活血复脉功效的片剂及制备方法
MX2010001047A (es) * 2007-08-02 2010-03-03 Teijin Pharma Ltd Agente preventivo o agente terapéutico para enfermedades provocadas por metabolismo óseo anormal.
KR20100136967A (ko) * 2008-02-15 2010-12-29 썬 파마 어드밴스트 리서치 컴패니 리미티드 파열 효과가 감소된 방출 제어 경구 정제
CN118370733B (zh) * 2024-06-21 2024-10-01 山东新时代药业有限公司 一种钙代谢调节药物氯膦酸二钠片及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2813121A1 (de) * 1977-03-29 1978-10-12 Procter & Gamble Verwendung von dichlormethan-diphosphonatverbindungen bei der bekaempfung von collagen-erkrankungen und zur wundheilung
US4634691A (en) * 1980-10-07 1987-01-06 The Procter & Gamble Company Method for inhibiting tumor metastasis
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
SE457326B (sv) * 1986-02-14 1988-12-19 Lejus Medical Ab Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa
DE3767998D1 (de) * 1986-12-20 1991-03-14 Boehringer Mannheim Gmbh Clodronat-haltige arzneimittel und verfahren zur herstellung derselben.
DE3804686A1 (de) * 1988-02-15 1989-08-24 Henkel Kgaa Arzneimittel mit einer kombination von cytostatika bzw. hormontherapeutika und phosphonoderivaten
FR2629716B1 (fr) * 1988-04-07 1991-07-19 Sanofi Sa Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique
FI83421C (fi) † 1989-06-21 1991-07-10 Huhtamaeki Oy Foerfarande foer framstaellning av farmakologiskt anvaendbara metylenbisfosfonsyraderivat.
CA2101275C (en) * 1991-02-26 1998-08-04 Jocelyn Elaine Mcosker Methods for the treatment of osteoporosis
SE501389C2 (sv) † 1992-04-24 1995-01-30 Leiras Oy Farmaceutiskt preparat och förfarande för dess framställning
WO1994014455A1 (en) * 1992-12-23 1994-07-07 Merck & Co., Inc. Bisphosphonate/estrogen therapy for treating and preventing bone loss

Also Published As

Publication number Publication date
EP0625355B2 (de) 2003-06-25
PL307133A1 (en) 1995-05-02
GR3017547T3 (en) 1995-12-31
AU687744B2 (en) 1998-03-05
NO944405D0 (no) 1994-11-17
KR960702322A (ko) 1996-04-27
KR100263284B1 (ko) 2000-08-01
IL106743A (en) 1999-11-30
GR940300095T1 (en) 1995-01-31
BR9307859A (pt) 1996-01-09
PL173026B1 (pl) 1998-01-30
CN1041797C (zh) 1999-01-27
FI111519B (fi) 2003-08-15
RU2134103C1 (ru) 1999-08-10
ES2065313T1 (es) 1995-02-16
EP0697890A1 (de) 1996-02-28
IL106743A0 (en) 1993-12-08
AU4702093A (en) 1994-12-12
SK4895A3 (en) 1997-01-08
UA39884C2 (uk) 2001-07-16
CZ10095A3 (en) 1995-10-18
TW350772B (en) 1999-01-21
ES2065313T5 (es) 2004-01-01
AT128U1 (de) 1995-03-27
JP3699110B2 (ja) 2005-09-28
FI945313A0 (fi) 1994-11-11
NO944405L (no) 1994-11-24
DK0625355T5 (da) 2003-12-01
HUT70214A (en) 1995-09-28
JPH08509697A (ja) 1996-10-15
CN1095267A (zh) 1994-11-23
HU9403160D0 (en) 1995-02-28
HU220872B1 (en) 2002-06-29
US5650168A (en) 1997-07-22
CZ287984B6 (cs) 2001-03-14
NZ254765A (en) 1997-02-24
DK0625355T4 (da) 2003-10-06
ES2065313T3 (es) 1995-12-01
WO1994026310A1 (de) 1994-11-24
FI945313A (fi) 1994-12-13
ATE128363T1 (de) 1995-10-15
DK0625355T3 (da) 1995-12-27
CA2162470C (en) 1998-06-16
NO307548B1 (no) 2000-04-25
EP0625355B1 (de) 1995-09-27
DE59300688D1 (de) 1995-11-02
EP0625355A1 (de) 1994-11-23
CA2162470A1 (en) 1994-11-24

Similar Documents

Publication Publication Date Title
CA2301185C (en) Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
US20110177168A1 (en) Composition
SK281193B6 (sk) Tableta so zlepšenou biodostupnosťou účinnej látky, kyseliny klodrónovej, spôsob jej výroby a použitie mikrokryštalickej celulózy
US20090074854A1 (en) Combined-step process for pharmaceutical compositions
PL199779B1 (pl) Tabletka o dużej zawartości monosulfonianu 4-(4-metylopiperazyn-1-ylometylo)-N-[4-metylo-3-(4-pirydyn-3-ylo)pirymidyn-2-yloamino)fenylo]-benzamidu i sposób jej wytwarzania
US20060222703A1 (en) Pharmaceutical composition and preparation method thereof
HU224983B1 (en) Swallow tablet comprising paracetamol
CZ287558B6 (en) Pharmaceutical preparation
US20210401748A1 (en) Powder for oral suspension containing lamotrigine
FI89238B (fi) Foerfarande foer framstaellning av kompressionsbelagda tabletter
EA003878B1 (ru) Способ получения жевательной таблетки с высоким содержанием n-ацетилцистеина и таблетка, полученная этим способом
SK283249B6 (sk) Tableta vyrobiteľná priamym tabletovaním, obsahujúca aktívnu látku kyselinu 4-amino-1-hydroxybutylidén-1,1-bisfosfónovú a spôsob jej výroby
DE69733752T2 (de) Arzneimittel enthaltend oxaprozin-natriumsalz,-kaliumsalz, oder-tris(hydroxymethyl)aminomethansalz
SK1752001A3 (en) Pharmaceutical compositions comprising ibuprofen and domperidone
JP2002532429A (ja) 薬学的処方物
IL139407A (en) Oral preparations containing -8 chloro-6, 11 - dihydro-11 - (-4-piperidaldehyde) - H5-benzo [5, 6] cyclohepta [1, -2 [b-pyridine
SK279740B6 (sk) Spôsob výroby
AU756338B2 (en) Stabile compositions comprising levosimendan and alginic acid
SK18582000A3 (sk) Obalené cyklofosfamidové tablety
CA1229552A (en) Cimetidine compositions
JP2005132788A (ja) 口腔内崩壊錠
RU2321405C2 (ru) Лекарственное средство, обладающее анальгезирующим, жаропонижающим и психостимулирующим действием, и способ его получения
SK11072000A3 (sk) Tiagabínové prostriedky s predĺženým uvoľňovaním so zníženými vedľajšími účinkami
RU2240120C1 (ru) Фармацевтический состав для улучшения мозгового кровообращения (винпомакс) и способ его получения

Legal Events

Date Code Title Description
PC4A Assignment and transfer of rights

Owner name: RIEMSER ARZNEIMITTEL AG, GREIFSWALD - INSEL RI, DE

Free format text: FORMER OWNER: ROCHE DIAGNOSTICS GMBH, MANNHEIM-WALDHOF, DE

Effective date: 20120116

MK4A Patent expired

Expiry date: 20130724